<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Columnar lined oesophagus</z:e> (<z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>) carries a risk for the development of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mpath ids='MPATH_129'>Epithelial dysplasia</z:mpath> appears to be a precursor but the utility of this marker for predicting subsequent <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> is unsettled </plain></SENT>
<SENT sid="2" pm="."><plain>We therefore prospectively studied 81 patients with histologically proven columnar epithelium of at least the distal 3 cm of the tubular oesophagus with regular endoscopic biopsies for a total of 289.2 patient years (mean 3.6 years, range 0.5-8) </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty three patients (28%) had <z:mpath ids='MPATH_129'>epithelial dysplasia</z:mpath> detected during follow up </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients with persistent high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> present on initial biopsies developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> after 2.6-4.5 years, despite the absence of gross macroscopic change </plain></SENT>
<SENT sid="5" pm="."><plain>The initial single layer pleomorphic high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in one patient regressed to low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> which has persisted for 1.5 years </plain></SENT>
<SENT sid="6" pm="."><plain>Of 10 patients with initial low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, one progressed to <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in 4.3 years </plain></SENT>
<SENT sid="7" pm="."><plain>The low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> persisted unchanged in seven patients for 1.5-7 years and appears to have regressed in two patients after three to five years </plain></SENT>
<SENT sid="8" pm="."><plain>Ten patients developed low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> during the surveillance period </plain></SENT>
<SENT sid="9" pm="."><plain>This has persisted unchanged in six patients from 0.5-5 years, regressed in three for 0.5-5 years and has appeared after the first yearly biopsy in one patient </plain></SENT>
<SENT sid="10" pm="."><plain>No patient without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> has developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="11" pm="."><plain>The incidence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in this study is one case per 96 patient years </plain></SENT>
<SENT sid="12" pm="."><plain>This is 61 times (95% confidence limits 12-176) the age adjusted incidence of <z:e sem="disease" ids="C0546837" disease_type="Neoplastic Process" abbrv="">oesophageal cancer</z:e> in Australia </plain></SENT>
<SENT sid="13" pm="."><plain>Persistent high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> appears to be a sensitive indicator for the development of subsequent <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
</text></document>